HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

seryl- leucyl- isoleucyl- - glycyl- lysyl- valine

derived from amino-terminus of proteinase-activated receptor 2 (PAR-2)
Also Known As:
SLIGKV; Ser-Leu-Ile-Gly-Lys-Val
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Egami, Hiroshi: 1 article (04/2006)
2. Ogawa, Michio: 1 article (04/2006)
3. Kamohara, Hidenobu: 1 article (04/2006)
4. Hidaka, Hideki: 1 article (04/2006)
5. Takahashi, Masahumi: 1 article (04/2006)
6. Ishikawa, Shinji: 1 article (04/2006)
7. Ikeda, Osamu: 1 article (04/2006)
8. Ishiko, Takatoshi: 1 article (04/2006)
9. Yamada, Nobuya: 1 article (06/2004)
10. Inoue, Masafumi: 1 article (06/2004)

Related Diseases

1. Pancreatic Neoplasms (Pancreatic Cancer)
2. Neoplasms (Cancer)
3. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. Trypsin
2. Phosphotransferases (Kinase)

Related Therapies and Procedures

1. Aftercare (After-Treatment)